Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Acta Clinica Belgica
|
July 19, 2016
Abscopal effect in metastatic renal cell carcinoma
Mieke Van de Walle, Jan Demol, Lorenzo Staelens, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
December 14, 2016
Virtual anatomical reconstruction of large acetabular bone defects using a statistical shape model
Peter Vanden Berghe, Jan Demol, Frederik Gelaude, et al.
Biomaterials
|
October 1, 2010
Towards a quantitative understanding of oxygen tension and cell density evolution in fibrin hydrogels
Jan Demol, Dennis Lambrechts, Liesbet Geris, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
March 20, 2014
Computed tomography-based joint locations affect calculation of joint moments during gait when compared to scaling approaches
Ward Bartels, Jan Demol, Frederik Gelaude, et al.
Biomechanics and Modeling in Mechanobiology
|
May 12, 2012
Modelling the effect of repositioning on the evolution of skeletal muscle damage in deep tissue injury
Jan Demol, Dorien Van Deun, Bart Haex, et al.
The Journal of Molecular Diagnostics : JMD
|
November 9, 2024
Surveillance of Disease Progression in Metastatic Breast Cancer by Molecular Counting of Circulating Tumor DNA Using Plasma-SeqSensei Breast Cancer in Vitro Diagnostics Assay
Geert A Martens, Jan Demol, Franceska Dedeurwaerdere, et al.
Investigational New Drugs
|
November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer
Francesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Breast Cancer Research and Treatment
|
September 5, 2009
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
Evandro de Azambuja, Worta McCaskill-Stevens, Prudence Francis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, et al.
Breast Cancer Research and Treatment
|
June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study
Patrick Neven, Robert Paridaens, Gino Pelgrims, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Acta Clinica Belgica
|
July 19, 2016
Abscopal effect in metastatic renal cell carcinoma
Mieke Van de Walle, Jan Demol, Lorenzo Staelens, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
December 14, 2016
Virtual anatomical reconstruction of large acetabular bone defects using a statistical shape model
Peter Vanden Berghe, Jan Demol, Frederik Gelaude, et al.
Biomaterials
|
October 1, 2010
Towards a quantitative understanding of oxygen tension and cell density evolution in fibrin hydrogels
Jan Demol, Dennis Lambrechts, Liesbet Geris, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
March 20, 2014
Computed tomography-based joint locations affect calculation of joint moments during gait when compared to scaling approaches
Ward Bartels, Jan Demol, Frederik Gelaude, et al.
Biomechanics and Modeling in Mechanobiology
|
May 12, 2012
Modelling the effect of repositioning on the evolution of skeletal muscle damage in deep tissue injury
Jan Demol, Dorien Van Deun, Bart Haex, et al.
The Journal of Molecular Diagnostics : JMD
|
November 9, 2024
Surveillance of Disease Progression in Metastatic Breast Cancer by Molecular Counting of Circulating Tumor DNA Using Plasma-SeqSensei Breast Cancer in Vitro Diagnostics Assay
Geert A Martens, Jan Demol, Franceska Dedeurwaerdere, et al.
Investigational New Drugs
|
November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer
Francesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Breast Cancer Research and Treatment
|
September 5, 2009
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
Evandro de Azambuja, Worta McCaskill-Stevens, Prudence Francis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, et al.
Breast Cancer Research and Treatment
|
June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study
Patrick Neven, Robert Paridaens, Gino Pelgrims, et al.
Page
of 1